DNA Bridges^®, - Bridging Science and Products
Expert consulting and professional services in the biotechnology, pharmaceutical and diagnostic industries.  Strategic solutions based
on 30 years of industry experience.
 

home hot topics/news

ARCHIVES  2010 | 2009 | 2008 | 2007 |2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000

• June 16, 2010
  Minapharm Acquires Majority Stake in ProBioGen AG; Dr. Wieland Wolf Appointed New CEO
  More 
   
• June 14, 2010
  to-BBB receives positive opinion for Orphan Drug Designation
  More 
   
• May 17, 2010
  Bayer HealthCare Enhances U.S. Research Strategy with New Innovation Center
  More 
   
• April 29, 2010
  BioMarin Reports Positive Results for Phase I/II Trial for BMN 110 for MPS IVA
  More 
   
• January 07, 2010
  SK3 Group Announces Healthcare of Today's Acquisition of MacuCLEAR
  More 
   
• Cell Therapy is Alive and Well
  By Cori Gorman, Ph.D., MBA, DNA Bridges, Inc.
  Featured in Bio Show Daily, Tuesday, May 19, 2009. Page 22
  More 
   
• Personalized Medicine Can Increase Revenues
  By Cammie Edwards, Ph.D., DNA Bridges, Inc.
  Featured in Bio Show Daily, Tuesday, May 19, 2009. Page 33.
  More 
   

biopharma insight VOL1

55 New Montgomery Street, Suite 605
San Francisco, CA 94105
TEL 415 362-0442
FAX 415 536-2871

5 Bisbee Court, Suite 109-225
Santa Fe, NM 87508-1419
 TEL 505-473-2703
FAX 505-474-9032

Copyright © DNA Bridges^®, Inc. 2000-2009, ALL RIGHTS RESERVED.
LEGAL NOTICES AND DISCLAIMERS